Report Detail
Drug Abuse Testing Market to 2027 - Global Analysis and Forecasts by Product (Rapid Testing Devices, Analyzers and Consumables); Sample Type (Blood, Urine, Saliva and Other Sample Types); End User (Hospitals, Diagnostic Laboratories and Forensic Laboratories) and Geography
- RnM3728043 |
- 10 September, 2019 |
- Global |
- 155 Pages |
- The Insight Partners |
- Biotechnology
The global drug abuse testing market is expected to reach US$ 9,393.17 Mn in 2027 from US$ 5,783.71 Mn in 2018. The drug abuse testing market is estimated to grow with a CAGR of 5.7% from 2019-2027.
The market is driven by factors such as, increasing consumption of illicit drugs and laws and regulations related to drug abuse. However, dearth of trained laboratory professionals may limit the growth of the market to a certain extent.
Illicit drugs, including cocaine, amphetamines, heroin, hallucinogens are substances that can inhibit the central nervous system and also cause hallucinogenic effects. The National Household Survey on Drug Abuse (NSDUH) is a primary source of information on the patterns, prevalence, and consequences of alcohol, illegal drug use, and abuse in the general U.S. As per statistics provided by the National Survey on Drug Use and Health (NSDUH), approximately 19.7 million American adults (above 12 years of age) have faced a substance use disorder in 2017. According to SAMHSAM, marijuana is the most commonly used illicit drug in the United States. The laws regarding the use of marijuana have changed in several countries over the past decades. Marijuana classified as a Schedule I drug that is considered as having a high potential for drug abuse that has no currently accepted medical use in treatment in the United States yet. Almost 38% of the adult population in the U.S. have battled an illegal drug use disorder during the year 2017. Other than illicit drugs, the consumption of alcohol has observed among the individuals in the country. Nearly 74% of adults suffering from a substance use disorder in 2017 also struggled with an alcohol use disorder.
Across the United States, the increasing consumption of marijuana has a public health impact on local and state communities. As in results, people meeting the diagnostic standards for abuse or dependence on marijuana, which is the second leading factor for which people receive drug treatment (behind alcohol). As per the White House Office of National Drug Control Policy, the consequences of marijuana use have placed a substantial strain on the U.S. health care system. Therefore, owing to the factors mentioned above, the market for drug abuse testing is anticipated to grow significantly in the forecast period.
Global drug abuse testing were segmented by product, sample type and end user. The product segment was categorized as rapid testing services, analyzers and consumables. On the basis of sample type, the market is segmented as urine, saliva, blood and others. Based on the end user, the drug abuse testing market is segmented into hospitals, diagnostic laboratories and forensic laboratories.
Some of the major primary and secondary sources included in the report include, Americans with Disabilities Act (ADA), The Australian Health Practitioner Regulation Agency (APHRA), The German Medical Association (BÄK), Bureau of Labor Statistics (BLS), Business Monitor International (BMI), Comprehensive Addiction and Recovery Act (CARA), Canadian Drugs and Substances Strategy (CDSS), The Drug Commission of the German Medical Association (DCGMA) and among others.
TABLE OF CONTENTS
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Drug Abuse Testing Market – By Product
- 1.3.2 Global Drug Abuse Testing Market – By Sample Type
- 1.3.3 Global Drug Abuse Testing Market – By End User
- 1.3.4 Global Drug Abuse Testing Market – By Geography
2. Global Drug Abuse Testing Market – Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Global Drug Abuse Testing Market Landscape
- 4.1 Overview
- 4.2 Pest Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
- 4.3 Expert Opinion
5. Global Drug Abuse Testing Market – Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Increasing Consumption of Illicit Drugs
- 5.1.2 Laws and Regulations Related to Drug Abuse
- 5.2 Key Market Restraints
- 5.2.1 Dearth of Trained Laboratory Professionals
- 5.3 Key Market Opportunities
- 5.3.1 Growing Adoption of LIMS in Cannabis Testing Laboratories
- 5.3.2 Advances in Drug Testing Consumables:
- 5.4 Impact Analysis
6. Drug Abuse Testing Market – Global Analysis
- 6.1 Global Drug Abuse Testing Market Revenue Forecasts And Analysis
- 6.2 Global Drug Abuse Testing Market, By Geography - Forecasts And Analysis
- 6.3 Positioning Of Key Players
7. Global Drug Abuse Testing Market Analysis– by Product
- 7.1 Overview
- 7.2 Global Drug Abuse Testing Market Share by Product 2018 & 2027 (%)
- 7.3 Rapid Testing Devices
- 7.3.1 Overview
- 7.3.2 Rapid Testing Devices Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4 Analyzers
- 7.4.1 Overview
- 7.4.2 Analyzers Market Revenue and Forecast to 2027 (US$ Mn)
- 7.5 Consumables
- 7.5.1 Overview
- 7.5.2 Consumables Market Revenue and Forecast to 2027 (US$ Mn)
8. Global Drug Abuse Testing Market Analysis– by Sample Type
- 8.1 Overview
- 8.2 Global Drug Abuse Testing Market Share by Sample Type 2018 & 2027 (%)
- 8.3 Blood
- 8.3.1 Overview
- 8.3.2 Blood Market Revenue and Forecast to 2027 (US$ Mn)
- 8.4 Urine
- 8.4.1 Overview
- 8.4.2 Urine Market Revenue and Forecast to 2027 (US$ Mn)
- 8.5 Saliva
- 8.5.1 Overview
- 8.5.2 Saliva Market Revenue and Forecast to 2027 (US$ Mn)
- 8.6 Other Sample Types
- 8.6.1 Overview
- 8.6.2 Other Sample Types Market Revenue and Forecast to 2027 (US$ Mn)
9. Global Drug Abuse Testing Market Analysis– by End User
- 9.1 Overview
- 9.2 Global Drug Abuse Testing Market Share by End User 2018 & 2027 (%)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
- 9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
- 9.5 Forensic Laboratories
- 9.5.1 Overview
- 9.5.2 Forensic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
10. Drug Abuse Testing Market Revenue and Forecasts to 2027 – Geographical Analysis
- 10.1 North America Drug Abuse Testing Market Revenue And Forecasts To 2027
- 10.1.1 North America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.2 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.1.3 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.1.4 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.5 North America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.1.6 US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.6.1 US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.6.2 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.1.6.3 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.1.6.4 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.7 Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.7.1 Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.7.2 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.1.7.3 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.1.7.4 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.8 Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.8.1 Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.8.2 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.1.8.3 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.1.8.4 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2 Europe Drug Abuse Testing Market Revenue And Forecasts To 2027
- 10.2.1 Europe Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.2 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.2.3 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.2.4 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.5 Europe Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.2.6 UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.6.1 UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.6.2 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.2.6.3 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.2.6.4 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.7 Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.7.1 Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.7.2 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.2.7.3 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.2.7.4 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.8 France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.8.1 France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.8.2 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.2.8.3 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.2.8.4 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.9 Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.9.1 Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.9.2 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.2.9.3 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.2.9.4 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.10 Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.10.1 Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.10.2 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.2.10.3 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.2.10.4 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027
- 10.3.1 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.2 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.3.3 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.3.4 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.5 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.3.6 Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.6.1 Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.6.2 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.3.6.3 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.3.6.4 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.7 China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.7.1 China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.7.2 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.3.7.3 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.3.7.4 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.8 India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.8.1 India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.8.2 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.3.8.3 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.3.8.4 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.9 South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.9.1 South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.9.2 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.3.9.3 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.3.9.4 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.10 Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.10.1 Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.10.2 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.3.10.3 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.3.10.4 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.4 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027
- 10.4.1 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.4.2 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.4.3 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.4.4 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.4.5 Middle East & Africa Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.4.6 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.4.6.1 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.4.6.2 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
- 10.4.6.3 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By Sample Type (US$ Mn)
- 10.4.6.4 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
- 10.4.7 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.4.7.1 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.4.7.2 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
- 10.4.7.3 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By Sample Type (US$ Mn)
- 10.4.7.4 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
- 10.4.8 South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.4.8.1 South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.4.8.2 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.4.8.3 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.4.8.4 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.5 South And Central America Drug Abuse Testing Market Revenue And Forecasts To 2027
- 10.5.1 South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.2 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.5.3 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.5.4 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.5.5 South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.5.6 Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.6.1 Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.6.2 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.5.6.3 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.5.6.4 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.5.7 Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.7.1 Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.7.2 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 10.5.7.3 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
- 10.5.7.4 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Drug Abuse Testing Market– Industry Landscape
- 11.1 Overview
- 11.2 Comparative Company Analysis
- 11.3 Growth Strategies done by the companies in the Market, (%)
- 11.4 Organic Developments
- 11.4.1 Overview
- 11.5 Inorganic developments
- 11.5.1 Overview
12. Drug Abuse Testing Market–Key company profiles
- 12.1 OraSure Technologies, Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Financial Overview
- 12.1.4 Product Portfolio
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 UCP Biosciences
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Financial Overview
- 12.2.4 Product Portfolio
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 MEDACX Ltd.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Financial Overview
- 12.3.4 Product Portfolio
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Beckman Coulter, Inc. (Danaher)
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Financial Overview
- 12.4.4 Product Portfolio
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Alcolizer Pty Ltd.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Financial Overview
- 12.5.4 Product Portfolio
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Wondfo
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Financial Overview
- 12.6.4 Product Portfolio
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Redwood Toxicology LAboratory (Abbott)
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Financial Overview
- 12.7.4 Product Portfolio
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 F. Hoffmann-La Roche Ltd.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Financial Overview
- 12.8.4 Product Portfolio
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Siemens
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Financial Information
- 12.9.4 Product Portfolio
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Thermo Fisher Scientific, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Financial Information
- 12.10.4 Product Portfolio
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 12.11 Drägerwerk AG & Co. KGaA
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Financial Overview
- 12.11.4 Product Portfolio
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
- 12.12 American Screening Corporation, Inc
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Financial Overview
- 12.12.4 1.5.4 Product Portfolio
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
- 12.13 Mercedes Medical
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Financial Overview
- 12.13.4 Product Portfolio
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
- 12.14 Alfa Scientific Designs, Inc.
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Financial Overview
- 12.14.4 Product Portfolio
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
- 12.15 Express Diagnostics Int'l, Inc.
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Financial Overview
- 12.15.4 Product Portfolio
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
- 12.16 Omega Laboratories, Inc.
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Financial Overview
- 12.16.4 Product Portfolio
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
- 12.17 Laboratorio Sodré
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Financial Overview
- 12.17.4 Product Portfolio
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
Summary:
Get latest Market Research Reports on Drug Abuse Testing. Industry analysis & Market Report on Drug Abuse Testing is a syndicated market report, published as Drug Abuse Testing Market to 2027 - Global Analysis and Forecasts by Product (Rapid Testing Devices, Analyzers and Consumables); Sample Type (Blood, Urine, Saliva and Other Sample Types); End User (Hospitals, Diagnostic Laboratories and Forensic Laboratories) and Geography. It is complete Research Study and Industry Analysis of Drug Abuse Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
